LUCYNasdaqOphthalmic GoodsFiscal year ends December 31Also trades as LUCYW

Innovative Eyewear Inc

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 14, 2026

$0.80+0.01 (+1.03%)

Close on Oct 19, 2026

Market cap: $4.98M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Mar 31, 2026

Innovative Eyewear reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Innovative Eyewear's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Innovative Eyewear's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-17 reverse split on Aug 12, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LUCY.

Revenue growth62.6% · median 11.0%

Gross margin21.3% · median 57.0%

Net margin-285.2% · median -3.3%

Company	Revenue	Growth
WRBY	$911.61M	+11.0%
STAA	$339.59M	+51.3%
MSAI	$6.27M	+12.2%
VUZI	$5.91M	+6.8%
LUCY	$2.66M	+62.6%
VYCO	$1.81M	+1.6%

Company

Exchange: Nasdaq
Industry: Ophthalmic Goods
Fiscal year ends: December 31
Employees: 13
Auditor: Cherry Bekaert LLP
SEC CIK: 1808377

Advertisement
300 × 250